Valisure, a New Haven, CT-based healthcare company focused on independent quality assurance in pharmaceutical drugs, received an investment from AlleyCorp.

总部位于康涅狄格州纽黑文的医疗保健公司Valisure接受了AlleyCorp的投资，该公司专注于药品的独立质量保证。

The amount of the deal was not disclosed.

交易金额未披露。

The company intends to use the funds to accelerate its research and development efforts, expand its team of experts, and further strengthen its position as a market leader in the independent pharmaceutical quality assurance space.

该公司打算利用这些资金加速其研发工作，扩大其专家团队，并进一步加强其在独立药品质量保证领域的市场领导者地位。

Led by new CEO Chip Phillips, Valisure is a healthcare supply chain technology company whose mission is to provide transparency to quality and independent certification through chemical analysis. The services are being adopted by major public and private health systems.

Valisure由新任首席执行官Chip Phillips领导，是一家医疗保健供应链技术公司，其使命是通过化学分析提供质量透明度和独立认证。主要的公共和私人卫生系统正在采用这些服务。

Chip Phillips is an accomplished healthcare executive with a focus on the pharmacy service space. He brings a wealth of experience, having served as President of ANDA, a subsidiary of Teva Pharmaceutical Industries, and was an executive leader at CVS Health. At CVS, he spent time leading the Medicaid business, TheraCom, Inc., and Minute Clinic.

Chip Phillips是一位成功的医疗保健高管，专注于药房服务领域。他拥有丰富的经验，曾担任Teva Pharmaceutical Industries子公司ANDA的总裁，也是CVS Health的执行主管。在CVS，他曾负责医疗补助业务、TheraCom公司和Minute Clinic。

.

.

With Chip’s appointment as CEO, Valisure’s Co-Founder David Light assumed the role of President.

Chip被任命为首席执行官后，Valisure的联合创始人David Light担任总裁。

Likewise, Wolfgang Hinz, Ph.D., has assumed a leadership position as the Chief Scientific Officer, Adam Clark-Joseph, Ph.D., as Chief Analytics Officer, and Jill Nailor, R.Ph., has advanced to the position of Chief Business Development Officer.

同样，Wolfgang Hinz博士担任首席科学官的领导职位，Adam Clark Joseph博士担任首席分析官，Jill Nailor博士晋升为首席业务发展官。

FinSMEs

FinSME

28/02/2024

28/02/2024